Antonio De Martino

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.

Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine.

Journal: Frontiers in immunology

Published: December 22, 2025

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.

Journal: Journal of neurology

Published: May 23, 2025

Humic extracts from raw or composted coffee husks as novel chitosan crosslinkers for the synthesis of sustainable nanoparticles with antioxidant properties.

Humic extracts from raw or composted coffee husks as novel chitosan crosslinkers for the synthesis of sustainable nanoparticles with antioxidant properties.

Journal: International journal of biological macromolecules

Published: September 16, 2024

Ischemic stroke despite direct oral anticoagulation: what is hidden?

Ischemic stroke despite direct oral anticoagulation: what is hidden?

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: May 11, 2024

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.

ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.

Journal: Journal of neurology

Published: January 15, 2024

Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab.

Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab.

Journal: Journal of neuroimmunology

Published: February 03, 2023

Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea.

Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea.

Journal: International review of neurobiology

Published: August 29, 2022

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic.

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic.

Journal: Journal of neurology

Published: July 08, 2022

Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.

Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.

Journal: Multiple sclerosis and related disorders

Published: April 02, 2022

Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells.

Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells.

Journal: Multiple sclerosis and related disorders

Published: January 22, 2022

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab.

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab.

Journal: International journal of environmental research and public health

Published: June 24, 2021

Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.

Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.

Journal: Le infezioni in medicina

Published: March 05, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026